{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T21:09:26Z","timestamp":1783717766463,"version":"3.55.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003550","name":"Queensland Government","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003550","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejves.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Vascular and Endovascular Surgery"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.ejvs.2020.06.006","type":"journal-article","created":{"date-parts":[[2020,7,20]],"date-time":"2020-07-20T07:43:46Z","timestamp":1595231026000},"page":"452-460","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["A Randomised Controlled Trial Assessing the Effects of Peri-operative Fenofibrate Administration on Abdominal Aortic Aneurysm Pathology: Outcomes From the FAME Trial"],"prefix":"10.1016","volume":"60","author":[{"given":"Joseph V.","family":"Moxon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie E.","family":"Rowbotham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenna L.","family":"Pinchbeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon M.","family":"Lazzaroni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan K.","family":"Morton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corey S.","family":"Moran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Quigley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason S.","family":"Jenkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9173-3944","authenticated-orcid":false,"given":"Christopher M.","family":"Reid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doug","family":"Cavaye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rene","family":"Jaeggi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Golledge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejvs.2020.06.006_bib1","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1002\/bjs.10587","article-title":"Association between metformin prescription and growth rates of abdominal aortic aneurysms","volume":"104","author":"Golledge","year":"2017","journal-title":"Br J Surg"},{"key":"10.1016\/j.ejvs.2020.06.006_bib2","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.gheart.2013.12.010","article-title":"Global and regional burden of aortic dissection and aneurysms: mortality trends in 21 world regions, 1990 to 2010","volume":"9","author":"Sampson","year":"2014","journal-title":"Glob Heart"},{"key":"10.1016\/j.ejvs.2020.06.006_bib3","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/s41569-018-0114-9","article-title":"Abdominal aortic aneurysm: update on pathogenesis and medical treatments","volume":"16","author":"Golledge","year":"2019","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.ejvs.2020.06.006_bib4","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/joim.12958","article-title":"Lack of an effective drug therapy for abdominal aortic aneurysm","volume":"288","author":"Golledge","year":"2020","journal-title":"J\u00a0Intern Med"},{"key":"10.1016\/j.ejvs.2020.06.006_bib5","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ejvs.2018.09.020","article-title":"Editor's Choice \u2013 European Society for Vascular Surgery (ESVS) 2019 clinical practice guidelines on the management of abdominal aorto-iliac artery aneurysms","volume":"57","author":"Wanhainen","year":"2019","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.ejvs.2020.06.006_bib6","doi-asserted-by":"crossref","first-page":"4473","DOI":"10.1073\/pnas.87.12.4473","article-title":"Osteopontin\u2014a possible anchor of osteoclasts to bone","volume":"87","author":"Reinholt","year":"1990","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.ejvs.2020.06.006_bib7","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1172\/JCI12980","article-title":"Osteopontin as a means to cope with environmental insults: regulation of inflammation, tissue remodeling, and cell survival","volume":"107","author":"Denhardt","year":"2001","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.ejvs.2020.06.006_bib8","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1046\/j.1365-2613.2000.00163.x","article-title":"Osteopontin: a key cytokine in cell-mediated and granulomatous inflammation","volume":"81","author":"O'Regan","year":"2000","journal-title":"Int J Exp Pathol"},{"key":"10.1016\/j.ejvs.2020.06.006_bib9","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1161\/01.STR.0000129790.00318.a3","article-title":"Osteoprotegerin and osteopontin are expressed at high concentrations within symptomatic carotid atherosclerosis","volume":"35","author":"Golledge","year":"2004","journal-title":"Stroke"},{"key":"10.1016\/j.ejvs.2020.06.006_bib10","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1161\/01.ATV.0000074878.29805.D0","article-title":"Osteopontin deficiency attenuates atherosclerosis in female apolipoprotein E-deficient mice","volume":"23","author":"Matsui","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.ejvs.2020.06.006_bib11","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1161\/01.CIR.0000055739.13639.D7","article-title":"Osteopontin transgenic mice fed a high-cholesterol diet develop early fatty-streak lesions","volume":"107","author":"Isoda","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.ejvs.2020.06.006_bib12","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1161\/01.RES.0000227550.00426.60","article-title":"An osteopontin-NADPH oxidase signaling cascade promotes pro-matrix metalloproteinase 9 activation in aortic mesenchymal cells","volume":"98","author":"Lai","year":"2006","journal-title":"Circ Res"},{"key":"10.1016\/j.ejvs.2020.06.006_bib13","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1172\/JCI200318141","article-title":"Angiotensin II-accelerated atherosclerosis and aneurysm formation is attenuated in osteopontin-deficient mice","volume":"112","author":"Bruemmer","year":"2003","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.ejvs.2020.06.006_bib14","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1161\/01.ATV.0000172631.50972.0f","article-title":"Vitamin E inhibits abdominal aortic aneurysm formation in angiotensin II-infused apolipoprotein E-deficient mice","volume":"25","author":"Gavrila","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.ejvs.2020.06.006_bib15","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1161\/01.ATV.0000255560.49503.4e","article-title":"Association between osteopontin and human abdominal aortic aneurysm","volume":"27","author":"Golledge","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.ejvs.2020.06.006_bib16","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1186\/1471-2164-10-298","article-title":"Whole genome expression analysis within the angiotensin II-apolipoprotein E deficient mouse model of abdominal aortic aneurysm","volume":"10","author":"Rush","year":"2009","journal-title":"BMC Genomics"},{"key":"10.1016\/j.ejvs.2020.06.006_bib17","doi-asserted-by":"crossref","first-page":"12984","DOI":"10.18632\/oncotarget.3848","article-title":"Differential gene expression in human abdominal aortic aneurysm and aortic occlusive disease","volume":"6","author":"Biros","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejvs.2020.06.006_bib18","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.2337\/db06-1177","article-title":"PPARalpha agonists suppress osteopontin expression in macrophages and decrease plasma levels in patients with type 2 diabetes","volume":"56","author":"Nakamachi","year":"2007","journal-title":"Diabetes"},{"key":"10.1016\/j.ejvs.2020.06.006_bib19","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.phrs.2010.11.002","article-title":"Pleiotropic actions of fenofibrate on the heart","volume":"63","author":"Balakumar","year":"2011","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.ejvs.2020.06.006_bib20","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1080\/17512433.2017.1263565","article-title":"Pharmacological management of diabetic dyslipidemia","volume":"10","author":"Filippatos","year":"2017","journal-title":"Exp Rev Clin Pharmacol"},{"key":"10.1016\/j.ejvs.2020.06.006_bib21","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1097\/HCO.0b013e32832c0b3d","article-title":"Fibrates in the treatment of cardiovascular risk and atherogenic dyslipidaemia","volume":"24","author":"Wierzbicki","year":"2009","journal-title":"Curr Opin Cardiol"},{"key":"10.1016\/j.ejvs.2020.06.006_bib22","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.yjmcc.2006.05.013","article-title":"Attenuation of cardiac dysfunction by a PPAR-alpha agonist is associated with down-regulation of redox-regulated transcription factors","volume":"41","author":"Ichihara","year":"2006","journal-title":"J\u00a0Mol Cell Cardiol"},{"key":"10.1016\/j.ejvs.2020.06.006_bib23","doi-asserted-by":"crossref","first-page":"885","DOI":"10.2337\/diabetes.55.04.06.db05-1329","article-title":"Accelerated diabetic nephropathy in mice lacking the peroxisome proliferator-activated receptor alpha","volume":"55","author":"Park","year":"2006","journal-title":"Diabetes"},{"key":"10.1016\/j.ejvs.2020.06.006_bib24","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.atherosclerosis.2009.10.027","article-title":"Peroxisome proliferator-activated receptor ligands reduce aortic dilatation in a mouse model of aortic aneurysm","volume":"210","author":"Golledge","year":"2010","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ejvs.2020.06.006_bib25","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.ajpath.2012.04.015","article-title":"Fenofibrate increases high-density lipoprotein and sphingosine 1 phosphate concentrations limiting abdominal aortic aneurysm progression in a mouse model","volume":"181","author":"Krishna","year":"2012","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ejvs.2020.06.006_bib26","article-title":"Randomized placebo-controlled trial assessing the effect of 24-week fenofibrate therapy on circulating markers of abdominal aortic aneurysm: outcomes from the FAME -2 Trial","volume":"7","author":"Pinchbeck","year":"2018","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.ejvs.2020.06.006_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13063-016-1752-z","article-title":"Fenofibrate in the management of AbdoMinal aortic anEurysm (FAME): study protocol for a randomised controlled trial","volume":"18","author":"Rowbotham","year":"2017","journal-title":"Trials"},{"key":"10.1016\/j.ejvs.2020.06.006_bib28","doi-asserted-by":"crossref","first-page":"3515","DOI":"10.1002\/jcp.26203","article-title":"Fenofibrate reverses changes induced by high-fat diet on metabolism in mice muscle and visceral adipocytes","volume":"233","author":"Frias","year":"2018","journal-title":"J\u00a0Cell Physiol"},{"key":"10.1016\/j.ejvs.2020.06.006_bib29","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1111\/bph.13438","article-title":"Fenofibrate inhibits atrial metabolic remodelling in atrial fibrillation through PPAR-alpha\/sirtuin 1\/PGC-1alpha pathway","volume":"173","author":"Liu","year":"2016","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.ejvs.2020.06.006_bib30","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s12944-015-0032-3","article-title":"Pleiotropic effects of fenofibrate therapy on rats with hypertriglycemia","volume":"14","author":"Sun","year":"2015","journal-title":"Lipids Health Dis"},{"key":"10.1016\/j.ejvs.2020.06.006_bib31","doi-asserted-by":"crossref","first-page":"c332","DOI":"10.1136\/bmj.c332","article-title":"CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials","volume":"340","author":"Schulz","year":"2010","journal-title":"BMJ"},{"key":"10.1016\/j.ejvs.2020.06.006_bib32","series-title":"Anthropometrica","first-page":"27","article-title":"Measurement techniques in anthropometry","author":"Norton","year":"2000"},{"key":"10.1016\/j.ejvs.2020.06.006_bib33","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.atherosclerosis.2013.11.034","article-title":"Association of chronic kidney disease categories defined with different formulae with major adverse events in patients with peripheral vascular disease","volume":"232","author":"Golledge","year":"2014","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ejvs.2020.06.006_bib34","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.jvs.2017.06.090","article-title":"Circulating biomarkers are not associated with endoleaks after endovascular repair of abdominal aortic aneurysms","volume":"67","author":"Moxon","year":"2018","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.ejvs.2020.06.006_bib35","series-title":"Knitr: a General-Purpose Package for Dynamic Report Generation in R. R Package Version 1.28","author":"Xie","year":"2020"},{"key":"10.1016\/j.ejvs.2020.06.006_bib36","series-title":"Nlme: linear and nonlinear mixed effects models. R Package Version 31-137","author":"Pinheiro","year":"2018"},{"key":"10.1016\/j.ejvs.2020.06.006_bib37","series-title":"PairedData: Paired Data Analysis. R Package Version 1.1.1","author":"Champley","year":"2018"},{"key":"10.1016\/j.ejvs.2020.06.006_bib38","series-title":"Irr: various coefficients of interrater reliability and agreement. R Package Version 0.84.1","author":"Gamer","year":"2019"},{"key":"10.1016\/j.ejvs.2020.06.006_bib39","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.2353\/ajpath.2010.090416","article-title":"The novel association of the chemokine CCL22 with abdominal aortic aneurysm","volume":"176","author":"Golledge","year":"2010","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ejvs.2020.06.006_bib40","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1093\/eurheartj\/ehm557","article-title":"Reduced expansion rate of abdominal aortic aneurysms in patients with diabetes may be related to aberrant monocyte-matrix interactions","volume":"29","author":"Golledge","year":"2008","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ejvs.2020.06.006_bib41","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1159\/000163019","article-title":"Interaction between angiotensin II, osteoprotegerin, and peroxisome proliferator-activated receptor-gamma in abdominal aortic aneurysm","volume":"46","author":"Moran","year":"2009","journal-title":"J\u00a0Vasc Res"},{"key":"10.1016\/j.ejvs.2020.06.006_bib42","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/nrcardio.2009.102","article-title":"Biomarkers of abdominal aortic aneurysm progression. Part 2: inflammation","volume":"6","author":"Hellenthal","year":"2009","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.ejvs.2020.06.006_bib43","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/nrcardio.2009.80","article-title":"Biomarkers of AAA progression. Part 1: extracellular matrix degeneration","volume":"6","author":"Hellenthal","year":"2009","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.ejvs.2020.06.006_bib44","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1093\/eurheartj\/ehq171","article-title":"Evaluation of the diagnostic and prognostic value of plasma D-dimer for abdominal aortic aneurysm","volume":"32","author":"Golledge","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ejvs.2020.06.006_bib45","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1161\/CIRCULATIONAHA.108.802074","article-title":"Circulating markers of abdominal aortic aneurysm presence and progression","volume":"118","author":"Golledge","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.ejvs.2020.06.006_bib46","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/s41572-018-0030-7","article-title":"Abdominal aortic aneurysms","volume":"4","author":"Sakalihasan","year":"2018","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.ejvs.2020.06.006_bib47","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.ejvs.2007.02.020","article-title":"Factors affecting survival after endovascular aneurysm repair: results from a population based audit","volume":"34","author":"Boult","year":"2007","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.ejvs.2020.06.006_bib48","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.jvs.2018.12.059","article-title":"Real-world cost analysis of endovascular repair versus open repair in patients with nonruptured abdominal aortic aneurysms","volume":"71","author":"Gupta","year":"2020","journal-title":"J\u00a0Vasc Surg"}],"container-title":["European Journal of Vascular and Endovascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078588420305244?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078588420305244?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T11:54:39Z","timestamp":1761047679000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078588420305244"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":48,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["S1078588420305244"],"URL":"https:\/\/doi.org\/10.1016\/j.ejvs.2020.06.006","relation":{},"ISSN":["1078-5884"],"issn-type":[{"value":"1078-5884","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Randomised Controlled Trial Assessing the Effects of Peri-operative Fenofibrate Administration on Abdominal Aortic Aneurysm Pathology: Outcomes From the FAME Trial","name":"articletitle","label":"Article Title"},{"value":"European Journal of Vascular and Endovascular Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejvs.2020.06.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2020 Published by Elsevier B.V. on behalf of European Society for Vascular Surgery.","name":"copyright","label":"Copyright"}]}}